All In Biotech

Drug Trial Radar · NCT04435366

A Phase 3 Safety and Efficacy Study of Intravitreal Administration of Zimura (Complement C5 Inhibitor)

A Phase 3 Multicenter, Randomized, Double Masked, Sham- Controlled Clinical Trial to Assess the Safety and Efficacy of Intravitreal Administration of Zimura (Complement C5 Inhibitor) in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration

Last checked: Nov 20, 2026Latest source record: Oct 21, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 448 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

448

Actual

Start

Jun 22, 2020

Primary completion

Jul 25, 2022

Study completion Aug 22, 2023

Sponsor

Lead sponsor
IVERIC bio, Inc.Industry
Sponsor type
Industry
First posted
Jun 17, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 50 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The objectives of this study was to evaluate the safety and efficacy of avacincaptad pegol intravitreal administration in participants with geographic atrophy secondary to age-related macular degeneration (AMD)

Conditions

  • Geographic Atrophy
  • Macular Degeneration

Interventions

  • Avacincaptad PegolDrug

    Avacincaptad Pegol Intravitreal Injection

  • ShamDrug

    Sham Administration (includes placement of the blunt opening of an empty, needleless syringe barrel on the conjunctiva in the inferotemporal quadrant of the eyeball to simulate the pressure of an injection)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The Mean Rate of Growth (Slope) Estimated Based on GA Area Measured by Autofluorescence (FAF) at 3 Time Points: Baseline, Month 6, and Month 12Time frame: Baseline to month 12
  2. The Mean Rate of Growth (Slope) Estimated Based on GA Area Measured by FAF at 5 Timepoints: Baseline, Month 6, Month 12, Month 18, and Month 24Time frame: Baseline to month 24

Locations

205 sites in 20 countries. Site status is shown where the registry gives one.

  • Retina-Vitreous Associates Medical Group

    Beverly Hills, California

  • Retinal Diagnostic Center

    Campbell, California

  • Eye Medical Center of Fresno

    Fresno, California

  • Retina Consultants of Orange County

    Fullerton, California

  • University of California, San Diego

    La Jolla, California

  • Jules Stein Eye Institute/David Geffen School of Medicine

    Los Angeles, California

  • Northern California Retina Vitreous Associates

    Mountain View, California

  • California Retina Consultants

    Oxnard, California

  • Southern California Desert Retina Consultants

    Palm Desert, California

  • Doheny Eye Center, UCLA

    Pasadena, California

  • Retina Consultants of Southern California

    Redlands, California

  • Retinal Consultants Medical Group, Inc.

    Sacramento, California

  • Orange County Retinal Medical Group

    Santa Ana, California

  • University of Colorado

    Aurora, Colorado

  • Retina Consultants of Southern Colorado, P.C.

    Colorado Springs, Colorado

  • Colorado Retina Associates

    Lakewood, Colorado

  • Connecticut Eye Consultants, P.C.

    Danbury, Connecticut

  • Retina Group of New England, PC

    Waterford, Connecticut

  • Florida Eye Clinic

    Altamonte Springs, Florida

  • Rand Eye Institute

    Deerfield Beach, Florida

  • Retina Group of Florida

    Fort Lauderdale, Florida

  • Retina Health Center

    Fort Myers, Florida

  • National Ophthalmic Research Institute

    Fort Myers, Florida

  • VitreoRetinal Associates, P.A.

    Gainesville, Florida

  • Florida Eye Associates

    Melbourne, Florida

  • University of Miami-Bascom Palmer Eye Institute

    Miami, Florida

  • Retina Care Specialists

    Palm Beach Gardens, Florida

  • Retina Specialty Institute

    Pensacola, Florida

  • Retina Associates of Sarasota

    Sarasota, Florida

  • Retina Vitreous Associates of Florida

    St. Petersburg, Florida

  • East Florida Eye Institute

    Stuart, Florida

  • Southern Vitreoretinal Associates, PL

    Tallahassee, Florida

  • Center for Retina and Macula Disease

    Winter Haven, Florida

  • Southeast Retina Center

    Augusta, Georgia

  • Georgia Retina, P.C.

    Marietta, Georgia

  • Retina Consultants of Hawaii, Inc

    ‘Aiea, Hawaii

  • University Retina and Macula Associates, PC

    Lemont, Illinois

  • Illinois Eye Center

    Peoria, Illinois

  • Midwest Eye Institute

    Indianapolis, Indiana

  • Wolfe Eye Clinic

    West Des Moines, Iowa

Showing 40 of 205 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.